BEAM THERAPEUTICS INC
BEAMNASDAQ🏆 #1667 by market capEarnings Nov 3US Equity
$26.88▲ $0.02 (+0.09%)
Live1h▲ 0.0%
24h▲ 0.1%
7d▼ 0.7%
14d▲ 3.4%
30d▼ 13.3%
1y▲ 59.3%
🏦Market Cap
$2.76B
Small Cap
📈Revenue Growth (YoY)
+158.9%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
18.1x
Expensive
Otter Score
52
Weak
📊
Analyst Ratings
Price
$26.88
Total
27
Raised
4
Lowered
3
Avg PT
$54.75
H / L
$80 / $26
| Institution | Action | Rating | Date |
|---|---|---|---|
B of A Securities | Reiterated | Buy | 2026-07-08 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-07 |
Bernstein | Reiterated | Outperform | 2026-05-13 |
Citigroup | Reiterated | Buy | 2026-03-26 |
RBC Capital | Reiterated | Sector Perform | 2026-02-25 |
Wedbush | Reiterated | Outperform | 2026-02-25 |
JP Morgan | Reiterated | Overweight | 2025-10-09 |
Barclays | Reiterated | Equal Weight | 2025-08-06 |
Guggenheim | Reiterated | Buy | 2025-05-07 |
Wells Fargo | Reiterated | Overweight | 2025-05-07 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-12 |
Jones Trading | Upgraded | Hold → Buy | 2025-03-10 |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2025-03-10 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2024-11-06 |
Stifel | Reiterated | Buy | 2024-09-11 |
BMO Capital | Reiterated | Outperform | 2024-03-27 |
Jefferies | Downgraded | Buy → Hold | 2023-12-08 |
Credit Suisse | Reiterated | Neutral | 2023-08-09 |
SVB Leerink | Reiterated | Outperform | 2023-01-23 |
Redburn Partners | Reiterated | Buy | 2021-05-11 |
William Blair | Reiterated | Outperform | 2020-08-05 |
Argus | Downgraded | Buy → Hold | 2018-05-05 |
Stifel Nicolaus | Reiterated | Hold | 2014-04-01 |
SunTrust Robinson Humphrey | Reiterated | Neutral | 2014-01-15 |
ISI Group | Reiterated | Neutral | 2013-11-08 |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2012-10-22 |
Credit Agricole | Downgraded | Buy → Underperform | 2012-08-17 |
One row per institution, most recent rating